Novavax Stock on Track for Worst Day Since 2022

Novavax Inc (NASDAQ:NVAX) missed top- and bottom-line estimates for the fourth quarter. The company noted its plans to cut costs, and still narrowed losses from the fourth quarter despite slowing Covid-19 vaccine demand. NVAX is down 26.3% to trade at $4.43 at last check.The shares have struggled to stay above penny stock territory, while their 200-day moving average has acted as long-term pressure. If these losses hold, NVAX could mark its worst daily percentage loss since December 2022. In the past 12 mon ...